Latest Pioglitazone Stories
The Japanese drug maker that was recently ordered to pay $6 billion to a man who claimed that his bladder cancer diagnosis was caused by Actos, makes several other drugs with the same active ingredient.
Takeda pharmaceutical company and marketing partner Eli Lilly have now been ordered by a Federal Court to pay for a Plaintiff's cancer injuries in connection with the drug Actos.
The cancer information website Cancer Monthly says bladder cancer patients who took Actos should not wait to seek legal advice, despite drug maker’s plans to appeal a federal jury’s ruling.
A recent published review of the link between Actos and bladder cancer suggests that a federal jury’s judgment against the drug’s manufacturer is justified. Raleigh,
Days after a federal jury announced a $9 billion dollar judgment against the drug’s manufacturers, Cancer Monthly is encouraging bladder cancer patients to know their rights. Raleigh,
A Louisiana jury’s decision to award $9 billion in damages to a man who says his bladder cancer was caused by the drug Actos could pave a new legal path for other bladder cancer patients.
The Firm is evaluating Actos lawsuits on behalf of individuals who allegedly developed bladder cancer due to long-term use of Actos. New York, New York (PRWEB)
The Firm is filing Actos lawsuits on behalf of individuals who took Actos for an extended period of time and allegedly developed bladder cancer due to their use of the Type 2 diabetes medication.
Takeda Pharmaceuticals and marketing partner Eli Lilly & Co.
Takeda Pharmaceutical Co. and Eli Lilly & Co. must pay a total of $9 billion in punitive damages after they were found to have concealed diabetes drug, Actos’, cancer risks.
- A transitional zone between two communities containing the characteristic species of each.